{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:27:36Z","timestamp":1783506456680,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jacl.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T21:30:36Z","timestamp":1708464636000},"page":"e384-e393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-8865","authenticated-orcid":false,"given":"Karla","family":"Santo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-6582","authenticated-orcid":false,"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysson Nathan","family":"Girotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8409-8601","authenticated-orcid":false,"given":"Josue","family":"Nieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Monfardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Raupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Marton","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Berwanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Julia","family":"Machline-Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jacl.2024.02.005_bib0001","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth Gregory","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacl.2024.02.005_bib0002","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2024.02.005_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"2 Supl 1","key":"10.1016\/j.jacl.2024.02.005_bib0004","first-page":"1","article-title":"Update - Brazilian guidelines on dyslipidemia and atherosclerosis prevention","volume":"109","author":"Faludi","year":"2017","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2024.02.005_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/hrt.2007.140905","article-title":"Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?","volume":"95","author":"Kerr","year":"2009","journal-title":"Heart"},{"issue":"9841","key":"10.1016\/j.jacl.2024.02.005_bib0006","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"10195","key":"10.1016\/j.jacl.2024.02.005_bib0007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(19)31243-7","article-title":"Brazil's unified health system: the first 30 years and prospects for the future","volume":"394","author":"Castro","year":"2019","journal-title":"The Lancet"},{"issue":"23","key":"10.1016\/j.jacl.2024.02.005_bib0008","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1056\/NEJMp1501140","article-title":"Brazil's family health strategy \u2014 delivering community-based primary care in a universal health system","volume":"372","author":"Macinko","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2024.02.005_bib0009","article-title":"Assessing statins use in a real-world primary care digital strategy: a cross-sectional analysis of a population-wide digital health approach","volume":"23","author":"Machline-Carrion","year":"2023","journal-title":"Lancet Region Health - Am"},{"key":"10.1016\/j.jacl.2024.02.005_bib0010","unstructured":"\u00cdndice de Desenvolvimento Humano dos Munic\u00edpios: brazilian Institute of Geography and Statistics. Available from: https:\/\/cidades.ibge.gov.br\/brasil\/sp\/pesquisa\/37\/30255?tipo=ranking."},{"key":"10.1016\/j.jacl.2024.02.005_bib0011","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","article-title":"A caution regarding rules of thumb for variance inflation factors","volume":"41","author":"O'Brien","year":"2007","journal-title":"Qual Quant"},{"issue":"11","key":"10.1016\/j.jacl.2024.02.005_bib0012","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacl.2024.02.005_bib0013","first-page":"787","article-title":"Update - Brazilian guidelines on cardiovascular prevention","volume":"113","author":"Pr\u00e9coma","year":"2019","journal-title":"Arq Bras Cardiol"},{"issue":"13","key":"10.1016\/j.jacl.2024.02.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020395","article-title":"Compliance in primary prevention with statins and associations with cardiovascular risk and death in a low-risk population with type 2 diabetes mellitus","volume":"10","author":"Malmborg","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"9435","key":"10.1016\/j.jacl.2024.02.005_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacl.2024.02.005_bib0016","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.2022.12982","article-title":"Statin recommendations for primary prevention: more of the same or time for a change?","volume":"328","author":"Navar","year":"2022","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jacl.2024.02.005_bib0017","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2019.09.026","article-title":"Trends in lipid, lipoproteins, and statin use among U.S. Adults: impact of 2013 cholesterol guidelines","volume":"74","author":"Patel","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacl.2024.02.005_bib0018","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/S2214-109X(21)00551-9","article-title":"Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data","volume":"10","author":"Marcus","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"10","key":"10.1016\/j.jacl.2024.02.005_bib0019","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1080\/03007995.2018.1451312","article-title":"Statin use in Brazil: findings and implications","volume":"34","author":"do Nascimento","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1016\/j.jacl.2024.02.005_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2188\/jea.JE20200089","article-title":"Validity assessment of self-reported medication use for hypertension, diabetes, and dyslipidemia in a pharmacoepidemiologic study by comparison with health insurance claims","volume":"31","author":"Matsumoto","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jacl.2024.02.005_bib0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jclinepi.2017.10.013","article-title":"Self-reported medication use validated through record linkage to national prescribing data","volume":"94","author":"Hafferty","year":"2018","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T04:13:16Z","timestamp":1735531996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1933287424000254"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.02.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}